Cowen Inc’s Novartis NVS Stock Holding History

Cowen Inc’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-27,900	Closed	-$2.15M	–	431
2018 Q4	$2.15M	Buy	+27,900	New	+$2.17M	0.24%	93

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Cowen Inc's NVS Position: Q1 2019 in Review

Cowen Inc sold out of Novartis (NVS) in Q1 2019, closing a stake of 27,900 shares — an estimated $2.15M sold.

Cowen Inc first reported a position in NVS in Q4 2018 and held it in 1 quarter. The position peaked at $2.15M in Q4 2018. 1,134 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Cowen Inc reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Cowen Inc sold 27,900 Novartis shares in Q1 2019, an estimated $2.15M.
Cowen Inc first reported a position in Novartis in Q4 2018 and held it in 1 quarter.
Cowen Inc's Novartis position peaked at $2.15M in Q4 2018.
1,134 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Cowen Inc's 13F filing for Q1 2019, filed 14 May 2019.